首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1489237

全球植入式起搏器市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Implantable Pacemaker Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年05月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球植入式心律調節器市場需求預計將從 2023 年的 37.9 億美元達到 2032 年近 55.3 億美元的市場規模，2024-2054 年研究期間複合年成長率為 4.29%。

植入式心律調節器是一種調節心律不整或其他心臟病患者心跳的醫療設備。它透過手術植入皮下（通常靠近胸部），傳遞刺激心臟正常跳動的電脈衝。現代心律調節器是可編程的，可以根據患者的身體活動調整心律調節器。它們顯著提高心律不整患者的生活品質和存活率，提供可靠且持續的心臟支持。

市場動態

植入式起搏器市場是由心血管疾病（特別是心律不整）日益流行所推動的，這需要使用心律調節器來調節心律並預防併發症。全球人口老化極大地促進了這一需求，因為老年人更容易患有需要植入心律調節器的心臟疾病。心律調節器設計和功能方面的技術進步，例如無引線起搏器和電池壽命更長的設備的開發，提高了患者的治療效果和舒適度，從而促進了市場成長。此外，將遠端監控功能整合到現代起搏器中可以對患者進行持續監控和及時的醫療干預，從而改善心血管疾病的管理並減少頻繁去醫院的需要。對心臟病的認知和診斷的提高，加上醫療基礎設施的改善，尤其是在新興經濟體，也推動了植入式起搏器的採用。此外，支持性的政府政策和醫療保健報銷計劃使起搏器植入物更容易為更廣泛的患者群體所接受。隨著醫療保健提供者繼續優先考慮先進的心臟護理以及起搏器技術創新的進步，對植入式起搏器的需求預計將保持強勁，推動市場進一步擴張。然而，嚴格的監管要求和高昂的開發成本可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球植入式心律調節器市場的各個細分市場進行了包容性評估。植入式起搏器產業的成長和趨勢為本研究提供了整體方法。

市場區隔

植入式起搏器市場報告的這一部分提供了有關國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

單室
雙室
雙心室

按申請

心律不整
心房震顫
心塊
長QT症候群
充血性心臟衰竭
其他

按最終用途

醫院
門診設施

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲植入式心律調節器市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。植入式心律調節器市場的主要參與者包括波士頓科學公司、佐爾醫療公司、美敦力公司、百多力公司、微創科學公司、庫克、Medico SpA、Pacetronix、雅培、Osypka Medical GmbH。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：植入式心律調節器公司的競爭格局

植入式心律調節器市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Boston Scientific Corporation

公司簡介
公司收入
產品
最近的發展

Zoll Medical Corporation

公司簡介
公司收入
產品
最近的發展

Medtronic

公司簡介
公司收入
產品
最近的發展

Biotronik

公司簡介
公司收入
產品
最近的發展

MicroPort Scientific Corporation

公司簡介
公司收入
產品
最近的發展

Cook

公司簡介
公司收入
產品
最近的發展

Medico SpA

公司簡介
公司收入
產品
最近的發展

Pacetronix

公司簡介
公司收入
產品
最近的發展

Abbott

公司簡介
公司收入
產品
最近的發展

Osypka Medical GmbH

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112114603

The global demand for Implantable Pacemaker Market is presumed to reach the market size of nearly USD 5.53 Billion by 2032 from USD 3.79 Billion in 2023 with a CAGR of 4.29% under the study period 2024-2054.

An implantable pacemaker is a medical device that regulates the heartbeat in individuals with arrhythmias or other heart conditions. Surgically implanted under the skin, commonly near the chest, it delivers electrical impulses that stimulate the heart to beat normally. Modern pacemakers are programmable and can adjust their pacing in response to the patient's physical activity. They significantly improve the quality of life and survival rates for individuals with heart rhythm disorders, providing reliable and continuous cardiac support.

MARKET DYNAMICS

The implantable pacemaker market is driven by the increasing prevalence of cardiovascular diseases, particularly arrhythmias, which necessitate using pacemakers to regulate heart rhythms and prevent complications. The aging global population significantly contributes to this demand, as older adults are more prone to heart conditions that require pacemaker implantation. Technological advancements in pacemaker design and functionality, such as the development of leadless pacemakers and devices with longer battery life, enhance patient outcomes and comfort, thereby boosting market growth. Additionally, integrating remote monitoring capabilities in modern pacemakers allows for continuous patient monitoring and timely medical intervention, improving the management of cardiovascular conditions and reducing the need for frequent hospital visits. Increased awareness and diagnosis of heart conditions, coupled with improved healthcare infrastructure, especially in emerging economies, are also driving the adoption of implantable pacemakers. Moreover, supportive government policies and healthcare reimbursement programs make pacemaker implants more accessible to a broader patient population. As healthcare providers continue to prioritize advanced cardiac care and as innovation in pacemaker technology progresses, the demand for implantable pacemakers is expected to remain strong, driving further market expansion. However, stringent regulatory requirements and high development costs may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Implantable Pacemaker. The growth and trends of Implantable Pacemaker industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Implantable Pacemaker market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Single Chamber
Dual Chamber
Biventricular Chamber

By Application

Arrhythmias
Atrial Fibrillation
Heart Block
Long QT Syndrome
Congestive Heart Failure
Others

By End Use

Hospitals
Outpatient Facilities

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Implantable Pacemaker market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Implantable Pacemaker market include Boston Scientific Corporation, Zoll Medical Corporation, Medtronic, Biotronik, MicroPort Scientific Corporation, Cook, Medico SpA, Pacetronix, Abbott, Osypka Medical GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. IMPLANTABLE PACEMAKER - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End Use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL IMPLANTABLE PACEMAKER MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data
5.3. Analysis By Product
5.4. Single Chamber Historic and Forecast Sales By Regions
5.5. Dual Chamber Historic and Forecast Sales By Regions
5.6. Biventricular Chamber Historic and Forecast Sales By Regions

6. GLOBAL IMPLANTABLE PACEMAKER MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data
6.3. Analysis By Application
6.4. Arrhythmias Historic and Forecast Sales By Regions
6.5. Atrial Fibrillation Historic and Forecast Sales By Regions
6.6. Heart Block Historic and Forecast Sales By Regions
6.7. Long QT Syndrome Historic and Forecast Sales By Regions
6.8. Congestive Heart Failure Historic and Forecast Sales By Regions
6.9. Others Historic and Forecast Sales By Regions

7. GLOBAL IMPLANTABLE PACEMAKER MARKET ANALYSIS BY END USE

7.1. Overview By End Use
7.2. Historical and Forecast Data
7.3. Analysis By End Use
7.4. Hospitals Historic and Forecast Sales By Regions
7.5. Outpatient Facilities Historic and Forecast Sales By Regions

8. GLOBAL IMPLANTABLE PACEMAKER MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE IMPLANTABLE PACEMAKER COMPANIES

9.1. Implantable Pacemaker Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF IMPLANTABLE PACEMAKER INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Boston Scientific Corporation
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Zoll Medical Corporation
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Medtronic
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Biotronik
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. MicroPort Scientific Corporation
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Cook
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Medico SpA
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Pacetronix
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Abbott
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Osypka Medical GmbH
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments